EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence and Internet of Things Integration in Pharmaceutical Manufacturing: A Smart Synergy

Reshma Kodumuru iD, Soumavo Sarkar iD, Varun Parepally, Jignesh Chandarana iD

Pharmaceutics · 22.02.2025 · 17 (3) · 290

DOI: 10.3390/pharmaceutics17030290 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 22.02.2025. Verfasst von Reshma Kodumuru und 3 weiteren Autor:innen. Beteiligte Einrichtung: KBI Biopharma, Inc., Durham, NC 27704, USA. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The integration of artificial intelligence (AI) with the internet of things (IoTs) represents a significant advancement in pharmaceutical manufacturing and effectively bridges the gap between digital and physical worlds. With AI algorithms integrated into IoTs sensors, there is an improvement in the production process and quality control for better overall efficiency. This integration facilitates enabling machine learning and deep learning for real-time analysis, predictive maintenance, and automation—continuously monitoring key manufacturing parameters.

Objective

This paper reviews the current applications and potential impacts of integrating AI and the IoTs in concert with key enabling technologies like cloud computing and data analytics, within the pharmaceutical sector.

Results

Applications discussed herein focus on industrial predictive analytics and quality, underpinned by case studies showing improvements in product quality and reductions in downtime. Yet, many challenges remain, including data integration and the ethical implications of AI-driven decisions, and most of all, regulatory compliance. This review also discusses recent trends, such as AI in drug discovery and blockchain for data traceability, with the intent to outline the future of autonomous pharmaceutical manufacturing.

Conclusions

In the end, this review points to basic frameworks and applications that illustrate ways to overcome existing barriers to production with increased efficiency, personalization, and sustainability.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligence (AI)drug discoveryinternet of things (IOTs)machine learningreal-time monitoring

Autor:innen und Institutionen

  • KBI Biopharma, Inc., Durham, NC 27704, USA.
  • Novartis AG, East Hanover, NJ 07936, USA.
  • Chemical Engineering Department, Michigan Technological University, Houghton, MI 49931, USA.
  • Grail Inc., Menlo Park, CA 94025, USA.

ORCID-Profile: Reshma Kodumuru, Soumavo Sarkar, Jignesh Chandarana

Zitieren

APA

Kodumuru, R., Sarkar, S., Parepally, V., & Chandarana, J. (2025). Artificial Intelligence and Internet of Things Integration in Pharmaceutical Manufacturing: A Smart Synergy. Pharmaceutics, 17(3), 290. https://doi.org/10.3390/pharmaceutics17030290

Vancouver

Kodumuru R, Sarkar S, Parepally V, Chandarana J. Artificial Intelligence and Internet of Things Integration in Pharmaceutical Manufacturing: A Smart Synergy. Pharmaceutics. 2025;17(3):290. doi:10.3390/pharmaceutics17030290

BibTeX
@article{Kodumuru2025,
  author = {Kodumuru, Reshma and Sarkar, Soumavo and Parepally, Varun and Chandarana, Jignesh},
  title = {Artificial Intelligence and Internet of Things Integration in Pharmaceutical Manufacturing: A Smart Synergy},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {290},
  doi = {10.3390/pharmaceutics17030290}
}
Kostenlos starten →